1. bookTom 57 (2018): Zeszyt 4 (January 2018)
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
2545-3149
Pierwsze wydanie
01 Mar 1961
Częstotliwość wydawania
4 razy w roku
Języki
Angielski, Polski
Otwarty dostęp

VACCINES AGAINST ROTAVIRUS INFECTION

Data publikacji: 26 Feb 2022
Tom & Zeszyt: Tom 57 (2018) - Zeszyt 4 (January 2018)
Zakres stron: 313 - 327
Otrzymano: 01 May 2018
Przyjęty: 01 Sep 2018
Informacje o czasopiśmie
License
Format
Czasopismo
eISSN
2545-3149
Pierwsze wydanie
01 Mar 1961
Częstotliwość wydawania
4 razy w roku
Języki
Angielski, Polski

Albrecht P., Szajewska H.: Choroby przewodu pokarmowego u dzieci. WUM, Warszawa, 2011 s. 247 –225Search in Google Scholar

Arora R., Swaminathan S.: Ready to measure impact? The introduction of Rotavirus Vaccine in India. Indian Pediatr. 53, 565–567 (2016)Search in Google Scholar

Bernstein D.I., Sack D.A., Rothstein E., Reisinger K., Smith V.E., O’Sullivan D., Spriggs D.R., Ward R.L.: Efficacy of live, attenuated, human rotavirus vaccine 89–12 in infants: a randomised placebo-controlled trial. Lancet, 354, 287–290 (1999)10.1016/S0140-6736(98)12106-2Search in Google Scholar

Bhandari N., Bhan M.K. i wsp.: Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet, 383, 2136–2143 (2014)10.1016/S0140-6736(13)62630-6Search in Google Scholar

Bines J.E., Kirkwood C.D. i wsp.: Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis.15, 1389–1397 (2015)Search in Google Scholar

Bishop R.F., Barnes G.L., Cipriani E., Lund J.S.: Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. New Engl. J. Med.309, 72–76 (1983)10.1056/NEJM198307143090203Search in Google Scholar

Brandt C.D., Parrott R.H. i wsp.: Pediatric viral gastroenteritis during eight years of study. J. Clin. Microbiol.18, 71–78 (1983)Search in Google Scholar

Breiman R.F., Zaman K., Armah G., Sow S.O., Anh D.D., Victor J.C., Hille D., Ciarlet M., Neuzil K.M.: Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine. Vaccine, 30(Supl 1), 24–29 (2012)10.1016/j.vaccine.2011.08.124Search in Google Scholar

Bresee J.S., Glass R.I., Ivanoff B., Gentsch J.R.: Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine, 17, 2207–2222 (1999)10.1016/S0264-410X(98)00376-4Search in Google Scholar

Burnett E., Umesh P., Jacqueline T.: Rotavirus vaccines: Effectiveness, safety, and future directions. Pediatr. Drugs, 20, 223–233 (2018)Search in Google Scholar

Centers for Disease Control and Prevention.: Intussusception among recipients of rotavirus vaccine – United States, 1998– 1999. MMWR Morb. Mortal. Wkly. Rep.48, 577–581 (1999)Search in Google Scholar

Centers for Disease control and Prevention.: Postmarketing monitoring of intussuspection after RotaTeq vaccination – United States, February 2007. MMWR Morb. Mortal. Wkly. Rep. 56, 218–222 (2007)Search in Google Scholar

Centers for Disease Control and Prevention.: Rotavirus vaccine information statement, https://www.cdc.gov/vaccines/hcp/vis/ vis-statements/rotavirus.html (08.05.2018)Search in Google Scholar

Centers for Disease Control and Prevention.: Suspection of Rotawirus vaccine after reports of intussuspection-United States, 1999. MMWR Morb. Mortal. Wkly. Rep. 53, 786–789 (2004)Search in Google Scholar

Centre for Disease Control and Prevention.: Rotavirus surveillance – worldwide, MMWR Morb. Mortal. Wkly. Rep.60, 514–516 (2009)Search in Google Scholar

Charakterystyka Produktu Leczniczego Rotarix.: https:// ec.europa.eu/health/documents/community-register/2006/2006022110930/anx_10930_pl.pdf (08.05.2018)10.4172/2161-0711.1000631Search in Google Scholar

Charakterystyka Produktu Leczniczego RotaTeq.: https:// ec.europa.eu/health/documents/community-register/2006/2006062711652/anx_11652_pl.pdf (08.05.2018)10.4172/2161-0711.1000631Search in Google Scholar

Clark H.F., Bernstein D.I., Dennehy P.H.: Safety, efficacy and immunogenicity of live, quadrivalent human-bovine reasortant rotavirus vaccine in healthy infants. J. Pediatr.144, 184–190 (2004)10.1016/j.jpeds.2003.10.05414760258Search in Google Scholar

Clark H.F., Burke C.J., Volkin D.B.: Safety, immunogenicity and eficacy in healthy infants of G1 and G2 human reasortant rotavirus vaccine in a new stabilizer.buffer liquid formulation. Pediatr. Infect. Dis. J.22, 914–920 (2003)10.1097/01.inf.0000091887.48999.7714551493Search in Google Scholar

Cook S.M., Glass R.I., LeBaron C.W., Ho M.S.: Global seasonality of rotavirus infections. Bull. World Health Organ.68, 171–177 (1990)Search in Google Scholar

Crawford S.E., Estes M.K. i wsp.: Rotavirus infection. Nat. Rev. Dis. Primers, 3, 17083 (2017)10.1038/nrdp.2017.83585891629119972Search in Google Scholar

Cunliffe N.A., Das B.K., Ramachandran M., Bhan M.K., Glass R.I., Gentsch J.R.: Sequence analysis demonstrates that VP6, NSP1 and NSP4 genes of Indian neonatal rotavirus strain 116E are of human origin. Virus Genes, 15, 39–44 (1997)10.1023/A:1007958914141Search in Google Scholar

Cunliffe N.A., Dove W., Bunn J.E., Ben Ramadam M., Nyangao J.W., Riveron R.L., Cuevas L.E., Hart C.A.: Expanding global distribution of rotavirus serotype G9: detection in Libya, Kenya, and Cuba. Emerg. Infect. Dis. 7, 890 e2 (2001)10.3201/eid0705.017521Search in Google Scholar

Cunliffe N.A., Kilgore P.E., Bresee J.S., Steele A.D., Luo N., Hart C.A., Glass R.I.: Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull. World Health Organ.76, 525 e37 (1998)Search in Google Scholar

Curns A.T., Steiner C.A., Barrett M., Hunter K., Wilson E., Parashar U.D.: Reduction in acute gastroenteritis hospitalizations among U.S. children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 U.S. states. J. Infect. Dis.201, 1617–1624 (2010)Search in Google Scholar

Czarnecki M., Gładysz A.: Zakażenia rotawirusowe. Puls Medycyny, http://pulsmedycyny.pl/2581182,83427 (08.05.2018)Search in Google Scholar

Danchin M., Kirkwood C.D., Lee K.J., Bishop R.F., Watts E., Justice F.A., Clifford V., Cowley D., Buttery J.P., Bines J.E.: Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine. Vaccine,31, 2610–2016 (2013)10.1016/j.vaccine.2013.04.008Search in Google Scholar

Dang D.A., Nguyen V.T., Vu D.T., Nguyen T.H., Nguyen D.M., Yuhuan W., Baoming J., Nguyen D.H., Le T.L., Rotavin-M1 Vaccine Trial Group.: A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rota-vin-M1) in Vietnamese children. Vaccine, 30(Supl 1), 114–121 (2012)10.1016/j.vaccine.2011.07.118Search in Google Scholar

de Hoog M.L.A., Vesikari T., Giaquinto C., Huppertz H.I., Martinon-Torres F., Bruijning-Verhagen P.: Report of the 5th European expert meeting on rotavirus vaccination (EERO-VAC). Hum. Vaccin. Immunother. 14, 1027–1034 (2018)Search in Google Scholar

De Vos B., Vesikari T., Linhares A.C., Salinas B., Pérez-Schael I., Ruiz-Palacios G.M., Guerrero Mde L., Phua K.B., Delem A., Hardt K.: A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 23, 179–182 (2004)Search in Google Scholar

Delem A., Lobmann M., Zygraich N.: A bovine rotavirus developed as a candidate vaccine for use in humans. J. Biol. Stand. 12, 443–445 (1984)Search in Google Scholar

Dhingra M.S., Saluja T. i wsp.: Evaluation of safety and immunogenicity of a live attenuated tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus vaccine (BRV-TV) in healthy Indian adults and infants. Vaccine, 32(Supl 1), 117–123 (2014)10.1016/j.vaccine.2014.03.069Search in Google Scholar

European Centre for Disease Prevention and Control.: ECDC Expert opinion on rotavirus vaccination in infancy. Stockholm: ECDC (2017)Search in Google Scholar

Garbag-Chenon A., Fontaine J.L., Lasfargues G., Clark H.F., Guyot J., Le Moing G., Hessel L., Bricout F.: Reactogenicity and immunogenicity of rotavirus WC3 vaccine in 5–12 month old infants. Res. Virol.140, 207–217 (1989)10.1016/S0923-2516(89)80098-6Search in Google Scholar

Gentsch, J. R., Glass R.I.: Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J. Infect. Dis.192(Supl 1), 146–159 (2005)10.1086/431499Search in Google Scholar

Gothefors L., Wadell G., Juto P., Taniguchi K., Kapikian A.Z., Glass R.I.: Prolonged efficacy of rhesus rotavirus vaccine in Swedish children. J. Infect. Dis. 159, 753–757 (1989)Search in Google Scholar

Groome M., Cryz S. i wsp.: Safety and immunogenicity of a parental P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in south Africa: a randomized, double-blind, placebo-controlled trial. Lancet Infect. Dis.17, 843–853 (2017).Search in Google Scholar

Heaton P.M., Ciarlet M.: The pentavalent rotavirus vaccine: Discovery to licensure and beyond. Vaccines, Stanley Plotkin. Clin. Infect. Dis. 45, 1618–1624 (2007)Search in Google Scholar

Heliwich E.: Biegunki dziecięce (w) Choroby zakaźne i pasożytnicze – epidemiologia i profilaktyka, red. A. Baumann-Popczyk, M. Sadkowska-Todys, A. Zieliński, alfa-medica press, Bielsko-Biała, 2014, s. 24–27Search in Google Scholar

Hill H.A., Elam-Evans L.D., Yankey D., Singleton J.A., Dietz V.: Vaccination coverage among children aged 19–35 months – United States, 2015. MMWR Morb. Mortal. Wkly. Rep.65, 1065–1071 (2016)10.15585/mmwr.mm6539a4Search in Google Scholar

Hjelt K., Grauballe P.C., Henriksen L., Krasilnikoff P.A.: Rotavirus infections among the staff of a general paediatric department. Acta Paediatr. Scand. 74, 617–618 (1985)Search in Google Scholar

Hoshino, Y., Kapikian A.Z.: Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development. J. Health Popul. Nutr. 18, 5–14 (2000) https://www.sabin.org/12th-international-rotavirus-symposium-presentations (08.05.2018)Search in Google Scholar

Isanaka S., Grais R.F. i wsp.: Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger. New Engl. J. Med.376, 1121– 1130 (2017)Search in Google Scholar

Jiang V., Jiang B., Tate J., Parashar U.D., Patel M.M.: Performance of rotavirus vaccines in developed and developing countries. Hum. Vaccines,6, 532–542 (2010)10.4161/hv.6.7.11278Search in Google Scholar

Jin-song L., Bing C., Han-chun G., Dan-di L., Lin L., LI-li L., Na L., Zhao-Jun D.: Faecal shedding of rotavirus vaccine in Chinese children after vaccination with Lanzhou lamb rotavirus vaccine. Scientific Reports, 8, 1001 (2008)Search in Google Scholar

Joensuu J., Koskenniemi E., .Pang X.L., Vesikari T.: Randomised placebo-controlled trial of rhesus-human reasortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet, 350, 1205–1209 (1997)10.1016/S0140-6736(97)05118-0Search in Google Scholar

Jonesteller C.L., Burnett E., Yen C., Tate J.E., Parashar U.D.: Effectiveness of Rotavirus Vaccination: A systematic review of the first decade of global post-licensure data, 2006–2016. Clin. Infect. Dis.65, 840–850 (2017)10.1093/cid/cix36928444323Search in Google Scholar

Kang G., Kelkar S.D., Chitambar S.D., Ray P., Naik T.: Epidemiological profile of rotaviral infection in India: challenges for the 21st century. J. Infect. Dis.192, 120–126 (2005)10.1086/431496246402016088795Search in Google Scholar

Kapikian A., Hoshino Y.,Chanosk R., Perez-Schael I.: Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed ar preventing severe rotavirus diarrhoea in infants and young children. J. Infect. Dis. 174, 65–72 (1996)Search in Google Scholar

Karafillakis E., Hassounah S., Atchison C.: Effectiveness and impact of rotavirus vaccines in Europe, 2006–2014. Vaccine, 33,2097–2107 (2015)10.1016/j.vaccine.2015.03.01625795258Search in Google Scholar

Kirkwood CD, Ma LF, Carey ME, Steele AD.: The rotavirus vaccine development pipeline. Vaccine, DOI: 10.1016/j.vaccine. 2017.03.076 (2017).Search in Google Scholar

Korycka M.: Epidemiologia zakażeń rotawirusowych u dzieci, Przegl. Epidemiol. 55, 275–279 (2001)Search in Google Scholar

Kramer A., Schwebke I., Kampf G.: How long do nosocomial pathogens persist on inanimate surfaces? A systematic review.BMC Infectious Diseases, 16.08.2006, http://www.biomedcentral.com/1471-2334/6/130/prepub (10.04.2018)10.1186/1471-2334-6-130156402516914034Search in Google Scholar

Leino T., Ollgren J., Salo H., Tiihonen P., Kilpi T.: First year experience of rotavirus immunisation programme in Finland. Vaccine, 31, 176–182 (2012)10.1016/j.vaccine.2012.10.06823122991Search in Google Scholar

Lopez A.L., Raguindin P.F. i wsp.: Impact of rotavirus vaccine introduction in Agusan Del Sur, Philippines. Twelfth International Rotavirus Symposium, 7–9.09.2016 ,Search in Google Scholar

Luna E.J., Frazatti-Gallina N.M., Timenetsky M.C., Cardoso M.R., Veras M.A., Miraglia J.L., Escobar A.M., Grisi S.J., Raw I., Precioso A.R.: A phase I clinical trial of a new 5-valent rotavirus vaccine. Vaccine, 31, 1100–1105 (2013)10.1016/j.vaccine.2012.12.02023261048Search in Google Scholar

Madhi S.A., Neuzil K.M. i wsp.: Effect of human rotavirus vaccine on severe diarrhea in African infants. New Engl. J. Med. 362, 289–298 (2010)Search in Google Scholar

Meldunki Epidemiologiczne NIZP-PZH http://wwwold.pzh. gov.pl/oldpage/epimeld/index_p.html#01 (08.05.2018)Search in Google Scholar

Moon S., Wang Y., Edens C., Gentsch J.R., Prausnitz M.R., Jiang B.: Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine, 31, 3396–3402 (2013)10.1016/j.vaccine.2012.11.027461037423174199Search in Google Scholar

Mrukowicz J., Szajewska H., Vesikari T.: Options for the prevention of rotavirus disease other than vaccination. J. Pediatr. Gastr. Nutr. 46(Supl 2), 32–37 (2008)10.1097/MPG.0b013e31816f79b018460970Search in Google Scholar

Mrukowicz J.: Szczepienie przeciwko rotawirusom w praktyce lekarskiej. Aktualny (2017) stan wiedzy. Medycyna Praktyczna – Szczepienia, 4, 64–86 (2017)Search in Google Scholar

Murphy T., Gargiullo P.M., Wharton M.: More on rotavirus vaccination and intussuspection. New Eng. J. Med.436, 564–572 (2002)Search in Google Scholar

Naik S.P., Zade J.K., Sabale R.N., Pisal S.S., Menon R., Bankar S.G., Gairola S., Dhere R.M.: Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL®) Vaccine, 35, 2962–2969 (2017)Search in Google Scholar

Państwowa Inspekcja Sanitarna: Stan sanitarny kraju w roku 2016, https://gis.gov.pl/images/Stan_sanitarny_kraju_2016.pdf (08.05.2018)Search in Google Scholar

PATH: Phase I/II Descending Age Study of P2VP8 subunit parental rotavirus vaccine in Healthy Toddlers and Infants 2014, https://clinicaltrials.gov/ct2/show/NCT02109484 (08.05.2018)Search in Google Scholar

Payne D.C., NVSN i wsp. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 U.S. counties, 2006–2009. Clin. Infect. Dis.53, 245–253. (2011)Search in Google Scholar

Penelope H.: Dennehy Rotavirus Vaccines: an Overview. Clin. Microbiol. Rev.21198–208 (2008)10.1128/CMR.00029-07222383818202442Search in Google Scholar

Perez-Schael I., Gountinas M.J., Perez M., Pagone V., Rojas A.M., Gonzales R., Cunto W., Hoshino Y., Kapikan Z.: Efficacy of the rhesus rotavirus-based quadrivalnet vaccine in infants and Young children In Venezuela. New Engl. J. Med.337, 1181–1187 (1997)10.1056/NEJM1997102333717019337376Search in Google Scholar

Pulkowska-Nowocień A., Prędota D., Topczewska-Cabanek A., Życińska K., Wardyn K.A., Nitsch-Osuch A.: Stan zaszczepienia dzieci przeciw rotawirusom w wybranej poradni Podstawowej Opieki Zdrowotnej w Warszawie w latach 2006–2013. Fam. Med. Primary Care Rev. 16, 353–355 (2014)Search in Google Scholar

Ruiz-Palacios G.M., O’Ryan M. i wsp.: Safety and efficacy of a nattenuated vaccine againstsevere rotavirus gastroenteritis. New Engl. J. Med.354, 11–22 (2006)Search in Google Scholar

Santos N., Hoshino Y.: Global distribution of rotavirus sero-types/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol.15, 29–56 (2005)10.1002/rmv.448Search in Google Scholar

Santosham M., Davidson B.L. i wsp.: Efficacy and safety of high-dose rhesus-human reasortant rotavirus vaccine in native American populations. J. Pediatr.131, 632–638 (1997)Search in Google Scholar

Schwartz J.L.: The First Rotavirus Vaccine and the Politics of Acceptable Risk. Milbank Q. 90, 278–310 (2012)10.1111/j.1468-0009.2012.00664.xSearch in Google Scholar

Senturia Y.D., Peckham C.S., Cordery M., Chrystie I.A., Banatvala J.E., Abdree F.E.: Live attenuated oral ratavirus vaccine. Lancet, 2, 1091 (1987)10.1016/S0140-6736(87)91522-4Search in Google Scholar

Tate J.E., Burton A.H., Boschi-Pinto C., Parashar U.D.: Global, regional, and national estimates of rotavirus mortality in children < 5 years of age, 2000–2013. Clin. Infect. Dis.62(Supl 2), 96–105 (2016)10.1093/cid/civ1013Search in Google Scholar

Trang V.N., Braeckman T., Lernout T., Hau T.V., Anhle T.K., Luan le T., Van Damme P., Anh D.D.: Prevalence of rotavirus antibodies in breast milk and inhibitory effects to rotavirus vaccines. Hum. Vacc. Immunother. 10, 3681–3687 (2014)Search in Google Scholar

Velázquez F.R., Verstraeten T. i wsp.: Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr. Infect. Dis. J. 31, 736–744 (2012)Search in Google Scholar

Vesikari T., Giaquinto C., Huppertz H.: Clinical trials of rotavirus vaccines in Europe. Pediatr. Infect. Dis. J. 25, 42–47(2006)Search in Google Scholar

Vesikari T., Heaton M.D. i wsp.: Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New Engl. J. Med. 354,23–33 (2006)Search in Google Scholar

Vesikari T., Isolauri E., D’Hondt E., Delem A., Zissis G.: Protection of infants againts rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.Lancet, 1, 977–981 (1984)10.1016/S0140-6736(84)92323-7Search in Google Scholar

Vesikari T., Isolauri E., Delem A., d’Hondt E., AndréF.E., Beards G.M., Flewett T.H.: Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine strain in infants vaccinated before rotavirus epidemic. J. Pediatr.107, 189–194 (1985)10.1016/S0022-3476(85)80123-2Search in Google Scholar

Vesikari T., Maki M., Isolauri E.: Epidemiologic beckground for the need of rotavirus vaccine in Finland: preliminary experience of RIT 4237 strain of live attenuated rotavirus vaccine in adults. Dev. Biol. Stand.53, 229–236 (1983)Search in Google Scholar

Vesikari T., Ruuska T., Delem A., Andre F.E.: Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report. Pediatr. Infect. Dis. J. 6, 164–169 (1987)Search in Google Scholar

Vesikari T., Ruuska T., Delem A., Andree F.E., Beards G.M., Flewett T.H.: Efficacy of two doses RIT 4237 bovine rotavirus vaccine (at birth and 7 months of age) for prevention of rotavirus diarrhoea. Acta Peadiatr. Scand.80, 173–180 (1991)10.1111/j.1651-2227.1991.tb11830.x1852084Search in Google Scholar

World Health Organization: Rotavirus vaccines. WHO position paper– January 2013-Recomendations. Weekly Epidemiol. Rec. 88, 49–64 (2013)Search in Google Scholar

Zaman K., Victor J.C. i wsp.: Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial. Plos Med.14, e1002282 (2017)10.1371/journal.pmed.1002282539515828419095Search in Google Scholar

Zhen S.S., Wang X.Y. i wsp.: Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design. Emerg. Microbes Infec.4,e64 (2015)10.1038/emi.2015.64463193126576341Search in Google Scholar

Zieliński A.: Odporność zbiorowiskowa, (w) Wakcynologia, red. W. Magdzik, D. Naruszewicz-Lesiuk, A. Zieliński, alfa-medica press, Bielsko-Biała, 2007, s. 50–57Search in Google Scholar

Polecane artykuły z Trend MD

Zaplanuj zdalną konferencję ze Sciendo